Accessibility Menu

Almirall(FRA) E2Z

Market Cap€2.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€10.28
-0.96%
-0.10Today

Almirall Financials at a Glance

Market Cap

€2.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€602.71

Net Income (TTM)

€39.55

EPS (TTM)

€0.27

P/E Ratio

37.88

Dividend

€0.19

Beta (Volatility)

-0.05 (Low)

Price

€10.28

Volume

0

Open

€10.28

Previous Close

€10.28

Daily Range

€10.28 - €10.28

52-Week Range

€10.26 - €13.72

Estimated Earnings Date

N/A

E2Z News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Almirall

Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not Allocated Assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Industry

Pharmaceuticals

Employees

2,097

CEO

Carlos Gallardo Piqué, MBA

E2Z Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

3.95%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

2.64%

Dividend Yield

1.80%

Payout Ratio

N/A

Stock Overview

Market Cap

€2.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

217.78M

Volume

0

Avg. Volume

1.773

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Almirall Performance Analysis

Almirall annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 863,248,0004.4%
20232023-12-31EUR 894,516,0003.6%
20242024-12-31EUR 985,721,00010.2%
20252025-12-31EUR 1,108,084,00012.4%
Almirall annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.02N/A
20232023-12-31EUR -0.20N/A
20242024-12-31EUR 0.05N/A
20252025-12-31EUR 0.22349.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€311.72

N/A

Gross Profit

€80.28

N/A

Gross Margin

25.76%

N/A

Market Cap

€2.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€1.18

N/A

Employees

2,097

N/A

Net Income

€24.25

N/A

EBITDA

€77.72

N/A

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€675.92

N/A

Total Debt

€321.35

N/A

Accounts Receivable

€164.38

N/A

Inventory

€173.45

N/A

Long Term Debt

€303.77

N/A

Short Term Debt

€17.58

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

-23.52%

N/A

Free Cash Flow

€94.77

N/A

Operating Cash Flow

€79.37

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About E2Z

What is the current price of Almirall?

Almirall is trading at €10.28 per share.

What is the 52-week range for Almirall?

Over the past 52 weeks, Almirall has traded between €10.26 and €13.72.

How much debt does Almirall have?

As of the most recent reporting period, Almirall reported total debt of €321.35M.

How much cash does Almirall have on hand?

Almirall reported €354.57M in cash and cash equivalents in its most recent financial results.

What is Almirall’s dividend yield?

Almirall currently has a dividend yield of 1.80%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.